Capricor Therapeutics
CAPR
#7633
Rank
A$0.66 B
Marketcap
A$11.47
Share price
0.80%
Change (1 day)
28.79%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -A$0.2 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.16 Billion a decrease over its 2024 earnings that were of -A$61.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.2 Billion19.84%
2025 -A$0.16 Billion159.57%
2024 -A$61.14 Million81.57%
2023 -A$33.68 Million-23.2%
2022 -A$43.85 Million44.93%
2021 -A$30.26 Million46.61%
2020 -A$20.64 Million78.71%
2019 -A$11.55 Million-49.7%
2018 -A$22.96 Million-724.78%
2017 A$3.67 M-112.93%
2016 -A$28.42 Million46.27%
2015 -A$19.43 Million106.82%
2014 -A$9.4 Million-48.41%
2013 -A$18.21 Million977.23%
2012 -A$1.7 Million-77.11%
2011 -A$7.39 Million-22.35%
2010 -A$9.51 Million-20.17%
2009 -A$11.92 Million-41.17%
2008 -A$20.25 Million41.05%
2007 -A$14.36 Million1098.87%
2006 -A$1.2 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B-14,566.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.30 B-766.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.18 Billion 501.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.5 Billion 151.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$12.65 Million-93.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$24.96 Million-87.23%๐Ÿ‡บ๐Ÿ‡ธ USA